NCT00005973View on ClinicalTrials.gov

BMS-214662 in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

July 31, 2004

Conditions
Unspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

BMS-214662

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005973 - BMS-214662 in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter